Curegene
Shanghai
About Curegene
Curegene focuses on the treatment of anti-viral diseases as well as cardiovascular and cerebrovascular diseases. The company has made strides in the development of small molecules and nucleic acid pharmaceuticals and currently possesses the most advanced targeted prodrug and nucleic acid drug technology platforms.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Total funding: $27.9M
- Funding stage: Early Stage Venture
- Last round: Series B (May 2025)
- Website: curegene.com.cn
- Phone: 021-62376259
Industries & Categories
Health Care, Hospital, Therapeutics
Canonical: https://fsome.com/organization/curegene-11574 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.